• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌预后中CpG甲基化与免疫表型的孟德尔随机化分析。

Mendelian randomization analysis of CpG methylation and immune phenotypes in epithelial ovarian cancer outcomes.

作者信息

Li Jiawei, Luo Wanjun, Nie Daohong, Lin Zidan, Zhou Chenfei

机构信息

Department of Gynecology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China.

School of Medical South China University of Technology, Guangzhou, People's Republic of China.

出版信息

Epigenetics. 2025 Dec;20(1):2527145. doi: 10.1080/15592294.2025.2527145. Epub 2025 Jul 3.

DOI:10.1080/15592294.2025.2527145
PMID:40610364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12233829/
Abstract

Epithelial ovarian cancer (EOC) is a heterogeneous malignancy with distinct histological subtypes, and DNA methylation has emerged as a promising biomarker for early detection. However, the role of methylation patterns in EOC heterogeneity and prognosis remains unclear. In this study, genome-wide association studies (GWAS) data from the Ovarian Cancer Association Consortium (OCAC) and Methylation quantitative trait loci (mQTL) data from the Genetics of DNA Methylation Consortium (GoDMC) were analysed using two-sample Mendelian randomization (MR). We investigated the genetic effects of CpG methylation on the risk and prognosis of five major EOC histotypes. To further explore the mechanisms by which DNA methylation affects EOC outcomes, we performed mediation analysis to evaluate the role of immunophenotypes. Our analysis identified 94 CpG sites associated with high-grade serous ovarian cancer (HGSOC), 9 of which were linked to prognosis. Additional significant associations were found for clear cell, low-grade serous, endometrioid, and mucinous subtypes. Hypomethylation at specific CpG sites was linked to increased EOC risk and shorter survival. Mediation analysis revealed significant interactions between CpG methylation and immunophenotypes, suggesting that immune modulation mediates the effects of DNA methylation on EOC outcomes. These results provide novel insights into the importance of epigenetic and immune-related factors in EOC pathogenesis.

摘要

上皮性卵巢癌(EOC)是一种具有不同组织学亚型的异质性恶性肿瘤,DNA甲基化已成为一种有前景的早期检测生物标志物。然而,甲基化模式在EOC异质性和预后中的作用仍不清楚。在本研究中,我们使用两样本孟德尔随机化(MR)分析了来自卵巢癌协会联盟(OCAC)的全基因组关联研究(GWAS)数据和来自DNA甲基化遗传学联盟(GoDMC)的甲基化定量性状位点(mQTL)数据。我们研究了CpG甲基化对五种主要EOC组织学类型的风险和预后的遗传效应。为了进一步探索DNA甲基化影响EOC结局的机制,我们进行了中介分析以评估免疫表型的作用。我们的分析确定了94个与高级别浆液性卵巢癌(HGSOC)相关的CpG位点,其中9个与预后相关。在透明细胞、低级别浆液性、子宫内膜样和黏液性亚型中也发现了其他显著关联。特定CpG位点的低甲基化与EOC风险增加和生存期缩短有关。中介分析揭示了CpG甲基化与免疫表型之间的显著相互作用,表明免疫调节介导了DNA甲基化对EOC结局的影响。这些结果为表观遗传和免疫相关因素在EOC发病机制中的重要性提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8325/12233829/4c7f53ee3ea9/KEPI_A_2527145_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8325/12233829/45963bf7e369/KEPI_A_2527145_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8325/12233829/69f26720bba2/KEPI_A_2527145_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8325/12233829/a7a8989e2d35/KEPI_A_2527145_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8325/12233829/4c7f53ee3ea9/KEPI_A_2527145_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8325/12233829/45963bf7e369/KEPI_A_2527145_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8325/12233829/69f26720bba2/KEPI_A_2527145_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8325/12233829/a7a8989e2d35/KEPI_A_2527145_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8325/12233829/4c7f53ee3ea9/KEPI_A_2527145_F0004_OC.jpg

相似文献

1
Mendelian randomization analysis of CpG methylation and immune phenotypes in epithelial ovarian cancer outcomes.上皮性卵巢癌预后中CpG甲基化与免疫表型的孟德尔随机化分析。
Epigenetics. 2025 Dec;20(1):2527145. doi: 10.1080/15592294.2025.2527145. Epub 2025 Jul 3.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
SNP-associated differential methylation in : insights into genetic-epigenetic interactions.单核苷酸多态性(SNP)相关的差异甲基化:对遗传-表观遗传相互作用的见解
Epigenomics. 2025 Jun;17(9):579-588. doi: 10.1080/17501911.2025.2513215. Epub 2025 May 30.
4
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
5
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.聚(ADP-核糖)聚合酶(PARP)抑制剂治疗卵巢癌。
Cochrane Database Syst Rev. 2022 Feb 16;2(2):CD007929. doi: 10.1002/14651858.CD007929.pub4.
6
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer.晚期上皮性卵巢癌初始治疗中,术前新辅助化疗与手术加化疗的比较。
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD005343. doi: 10.1002/14651858.CD005343.pub7.
7
DNA Methylation-Regulated ZDHHC13 Promotes the Progression of Parkinson's Disease.DNA甲基化调控的ZDHHC13促进帕金森病的进展。
Mol Neurobiol. 2025 Mar 15. doi: 10.1007/s12035-025-04829-1.
8
[Multi-omics Mendelian randomization study on the causality between non-ionizing radiation and facial aging].[非电离辐射与面部衰老因果关系的多组学孟德尔随机化研究]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2025 Jun 20;41(6):594-603. doi: 10.3760/cma.j.cn501225-20240830-00320.
9
Association between the timing of childhood adversity and epigenetic patterns across childhood and adolescence: findings from the Avon Longitudinal Study of Parents and Children (ALSPAC) prospective cohort.儿童期逆境发生时间与儿童期和青春期表观遗传模式的关联:来自阿冯纵向研究父母与子女(ALSPAC)前瞻性队列的研究结果。
Lancet Child Adolesc Health. 2023 Aug;7(8):532-543. doi: 10.1016/S2352-4642(23)00127-X. Epub 2023 Jun 14.
10
Angiogenesis inhibitors for the treatment of epithelial ovarian cancer.血管生成抑制剂在治疗上皮性卵巢癌中的应用。
Cochrane Database Syst Rev. 2023 Apr 18;4(4):CD007930. doi: 10.1002/14651858.CD007930.pub3.

本文引用的文献

1
Common and novel haplotype structures between different types of cancer.不同类型癌症之间常见和新颖的单倍型结构。
Cancer Rep (Hoboken). 2024 Jun;7(6):e2107. doi: 10.1002/cnr2.2107.
2
Integrating muti-omics data to identify tissue-specific DNA methylation biomarkers for cancer risk.整合多组学数据以鉴定用于癌症风险的组织特异性 DNA 甲基化生物标志物。
Nat Commun. 2024 Jul 18;15(1):6071. doi: 10.1038/s41467-024-50404-y.
3
Impact of insomnia on ovarian cancer risk and survival: a Mendelian randomization study.失眠对卵巢癌风险和生存的影响:一项孟德尔随机化研究。
EBioMedicine. 2024 Jun;104:105175. doi: 10.1016/j.ebiom.2024.105175. Epub 2024 Jun 1.
4
Converting "cold" to "hot": epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells.将“冷”转化为“热”:通过调节肿瘤相关免疫抑制细胞来改善免疫治疗效果的表观遗传学策略。
Cancer Commun (Lond). 2024 Jun;44(6):601-636. doi: 10.1002/cac2.12546. Epub 2024 May 7.
5
A blueprint for tumor-infiltrating B cells across human cancers.一份关于人类癌症中肿瘤浸润性B细胞的蓝图。
Science. 2024 May 3;384(6695):eadj4857. doi: 10.1126/science.adj4857.
6
Global epidemiology of epithelial ovarian cancer.上皮性卵巢癌的全球流行病学。
Nat Rev Clin Oncol. 2024 May;21(5):389-400. doi: 10.1038/s41571-024-00881-3. Epub 2024 Mar 28.
7
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers.全表型孟德尔随机化分析 378142 例揭示八种常见癌症的风险因素。
Nat Commun. 2024 Mar 25;15(1):2637. doi: 10.1038/s41467-024-46927-z.
8
Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming.衣康酸盐通过代谢和表观遗传重编程调节 T 细胞失衡来改善自身免疫。
Nat Commun. 2023 Feb 27;14(1):984. doi: 10.1038/s41467-023-36594-x.
9
Ovarian cancer mutational processes drive site-specific immune evasion.卵巢癌突变过程驱动特定部位的免疫逃逸。
Nature. 2022 Dec;612(7941):778-786. doi: 10.1038/s41586-022-05496-1. Epub 2022 Dec 14.
10
Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.BRCA1 基因启动子甲基化与三阴性乳腺癌和高级别浆液性卵巢癌发病风险的相关性。
JAMA Oncol. 2022 Nov 1;8(11):1579-1587. doi: 10.1001/jamaoncol.2022.3846.